Stereotactic Intracerebral Injection of IPSC-DAPs in Patients with Parkinson's Disease

General Information

Summary Parkinson's disease is a progressive neurodegenerative disorder characterized by high morbidity due to the limited regenerative capacity of dopaminergic neurons in the brain. Current drug treatments primarily manage symptoms but do not halt or reverse neuronal loss. Cellular replacement therapy has emerged as a potential strategy to restore dopaminergic function and address the underlying neuronal deficits. This study aims to evaluate the safety, feasibility, and efficacy of transplanting dopaminergic neurons into the brain to improve motor function and quality of life in patients with advanced Parkinson's disease.
Description Patients with Parkinson's disease will be treated with autologous induced pluripotent stem cell-derived dopamine progenitor cells (iPSC-DAPs). These cells will be transplanted directly into the striatum to restore dopamine-producing capacity. Patients will be evaluated at 1, 3, 6, 9 and 12 months after transplantation for safety, feasibility, and efficacy.
Clinical trials phase Phase 1
Start date (estimated) 2025-05-15
End date (estimated) 2026-09-30
Clinical feature
Label Parkinson's disease
Link http://purl.obolibrary.org/obo/DOID_14330
Description A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions.; Xref MGI. OMIM mapping confirmed by DO. [SN].

Administrative Information

NCT number NCT06821529
ICTRP weblink https://trialsearch.who.int/Trial2.aspx?TrialID=NCT06821529
Other study identifiers
Name (2025)LSYD(0172)H
Source weblink https://clinicaltrials.gov/study/NCT06821529
Public contact
Email jialipu@zju.edu.cn
Public email jialipu@zju.edu.cn
First name Jiali
Last name Piu
Phone +86 13989468062
Country
China
Address freetext Second Affiliated Hospital, School of Medicine, Zhejiang University
Sponsors iCamuno Biotherapeutics Ltd

Cells

Which differentiated cell type is used
Label dopaminergic neuron
Link http://purl.obolibrary.org/obo/CL_0000700
Description A neuron that releases dopamine as a neurotransmitter.

Recruitment

Recruitment Status Not yet recruiting
Estimated number of participants 12